Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

330.38 +0.65 (+0.20%)
Streaming Delayed Price Updated: 10:49 AM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Critical Insights From Stryker Analyst Ratings: What You Need To Know
Via Benzinga
Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance
The company expects sales to grow 7% to 9% organically, above expectations. 
Via Investor's Business Daily
Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts
Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Stryker Stock Gains On Q4 Earnings, 2024 Outlook
Stryker Corp (NYSE: SYK) shares are trading higher in Tuesday's after-hours session after the company reported better-than-expected fourth-quarter financial results. 
Via Benzinga
Stryker: Q4 Earnings Insights
Via Benzinga
Earnings Preview For Stryker
Via Benzinga
How Is The Market Feeling About Stryker?
Via Benzinga
Earnings Scheduled For January 30, 2024
Companies Reporting Before The Bell • CommVault Systems (NASDAQ:CVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million. 
Via Benzinga
3 Robotics Stocks to Buy and Hold Forever: January 2024
Wager on these top robotics stocks to buy as the industry kicks in to overdrive offering robust long-term upside. 
Via InvestorPlace
Navigating 7 Analyst Ratings For Stryker
Via Benzinga
Here's How Much $100 Invested In Stryker 15 Years Ago Would Be Worth Today
Via Benzinga
STRYKER CORP (NYSE:SYK) Technical Analysis observations.
Technical Insights for STRYKER CORP (NYSE:SYK): Is a Breakout Imminent? 
Via Chartmill
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named Crown Castle Inc. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The 3 Best Robotics Stocks to Buy in January 2024
Get comprehensive insights on market trends and investment opportunities in the robotics sector, staying ahead in this rapidly evolving world. 
Via InvestorPlace
(SYK) - Analyzing Stryker's Short Interest
Via Benzinga
What Analysts Are Saying About Stryker Stock
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Stryker's Options Frenzy: What You Need to Know
Via Benzinga
Where Stryker Stands With Analysts
Via Benzinga
Peering Into Stryker's Recent Short Interest
Via Benzinga
3 Dividend Champions For Long-Term Income
The Dividend Champions have increased their payouts for over a quarter-century. 
Via Talk Markets
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $7,400 Today
Via Benzinga
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock. 
Via Investor's Business Daily
Looking Into Stryker's Recent Short Interest
Via Benzinga
The Latest Analyst Ratings for Stryker
Via Benzinga
Implants And Joint Replacement Company Stryker Tightens Annual Forecast On 'Positive Procedural Trends'
Stryker Corporation (NYSE: SYK) reported Q3 sales of $4.9 billion, up 9.6% Y/Y (+9.3% in constant currency), beating the consen 
Via Benzinga
Stryker Tumbles Despite Topping Sales, Earnings Expectations
Stryker stock tumbled late Thursday, though the company reported better-than-expected earnings and third-quarter sales. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.